Page 5 - Dynamic Precision Library News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Adagene Announces Updates to its Board of Directors

SAN DIEGO and SUZHOU, China, April 28, 2023 (GLOBE NEWSWIRE) Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology.

Hong kongUnited statesYumeng wangPeter luoYuwen liuMervyn turnerLefei sunHong kong university of scienceMerck research laboratoriesShanghai banking corporationUniversity of sheffieldAdagene incEuropean unionHavard universityCalifornia institute of technologyTechnology development

Adagene Inc (ADAG) Announces Board Changes

Adagene Inc (ADAG) Announces Board Changes
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongMervyn turnerYuwen liuLefei sunYumeng wangPeter luoShanghai banking corporationYale universityAdagene incBiotheus incDynamic precision libraryEuropean unionHong kong university of scienceMerck research laboratoriesHavard university

Adagene Presents Clinical Data for Anti-CTLA-4 SAFEbody® ADG126 Reinforcing Best-in-Class Safety Profile at Repeat Doses and Showing Early Efficacy Profile in Advanced/Metastatic Solid Tumors

- Results of dose escalation portion from phase 1b/2 trials of ADG126 in combination with anti-PD-1 therapies, including confirmed clinical responses, pave way for dose expansion in specific tumors - . | April 18, 2023

United statesAdagene incEuropean unionDynamic precision librarySafety profile reinforcedClinical responsesTumor shrinkageProlonged stable disease supportsDose expansion ongoingTumor potential shownAdagene inc stock exchangePress releaseUmors adag us0053291078

Adagene Presents Clinical Data for Anti-CTLA-4 SAFEbody®

- Results of dose escalation portion from phase 1b/2 trials of ADG126 in combination with anti-PD-1 therapies, including confirmed clinical responses, pave.

United statesEuropean unionAdagene incDynamic precision librarySafety profile reinforcedClinical responsesTumor shrinkageProlonged stable disease supportsDose expansion ongoingTumor potential shownNasdaq adagDagene inc

Adagene Reports Full Year 2022 Financial Results and Provides Corporate Update

Adagene Reports Full Year 2022 Financial Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJapan generalPeter luoPowerbody tcesFood drug administration project optimusDevelopment rd expensesBiovie incAdagene incEuropean unionDrug development departmentExchange commissionAdageneadagene incAmerican association for cancer researchFinancial measuresthe companyDynamic precision libraryGustave roussy cancer center